Back to results
US 12,746,256 B2Granted
Topical composition for treatment of pain and symptoms associated with rhinosinusitis, method of making, and method of use
AssigneeThree Fifths, LLC
InventorBrian D. Thomas, Sr.
Life of this patent
Estimating the term…
Abstract
A topical composition for the treatment of pain includes a hydrophilic carrier; a therapeutically active ingredient of potassium bitartrate and at least one of potassium chloride, calcium chloride, and magnesium chloride; at least one essential oil; and water.
Claims17
A method for treating pain and/or Rhinosinusitis symptoms in a subject, comprising:
- applying a therapeutically effective amount of a topical composition to skin or membrane(s) of the subject;
- wherein the topical composition comprises a homogeneous mixture of a hydrophilic carrier;
- a therapeutically active ingredient comprising potassium bitartrate and at least one of potassium chloride, calcium chloride, and magnesium chloride;
- at least one essential oil;
- and water;
- wherein the hydrophilic carrier comprises at least one of yellow mustard, lecithin, fatty acid esters, sodium stearoyl lactylate, ethoxylated alcohols, carboxylates, sodium isethionate, glycerol monostearate, cetyl alcohol, stearyl alcohol, silicone emulsifiers, or polyelectrolytes;
- and
- wherein the topical composition has been incubated for 24 hours to 3 weeks at 25° C. to 32° C. in a medium of KCl/water.
5 more elements
A method for treating pain and/or Rhinosinusitis symptoms in a subject, comprising:
- applying a therapeutically effective amount of a topical composition to skin or membrane(s) of the subject;
- wherein the topical composition comprises a homogeneous mixture of a hydrophilic carrier;
- a therapeutically active ingredient comprising potassium bitartrate and at least one of potassium chloride, calcium chloride, and magnesium chloride;
- at least one essential oil;
- and water;
- wherein the hydrophilic carrier is a sprayable carrier and the topical composition is a spray;
- and
- wherein the topical composition has been incubated for 24 hours to 3 weeks at 25° C. to 32° C. in a medium of KCl/water.
5 more elements
A method for treating pain in a subject, comprising:
- applying a therapeutically effective amount of a topical composition to skin of the subject;
- wherein the topical composition comprises a homogeneous mixture of about 1% to about 10% by volume of a hydrophilic carrier;
- a therapeutically active ingredient comprising about 0.2% to about 3% by volume of potassium bitartrate and about 0.1% to about 5% by volume of potassium chloride;
- about 1% to about 20% by volume of at least one essential oil;
- and about 20% to about 97% by volume of water and at least one of a parasept, a coolant, a perfume, or a surfactant;
- and
- wherein the topical composition has been incubated for 24 to 48 hours at 25° C. to 32° C. in a medium of KCl/water.
4 more elements
Dependencies are inferred from the claim text.